Khalil Abnous Selected Research

PicoGreen

8/2022	A highly sensitive fluorescent aptasensor for detection of prostate specific antigen based on the integration of a DNA structure and CRISPR-Cas12a.
9/2019	Fluorescent sensor for detection of miR-141 based on target-induced fluorescence enhancement and PicoGreen.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Khalil Abnous Research Topics

Disease

100	Neoplasms (Cancer) 09/2022 - 02/2011
28	Breast Neoplasms (Breast Cancer) 12/2022 - 01/2015
14	Colonic Neoplasms (Colon Cancer) 07/2022 - 10/2013
11	Carcinoma (Carcinomatosis) 12/2021 - 12/2014
11	Cardiotoxicity 01/2021 - 05/2010
9	Colorectal Neoplasms (Colorectal Cancer) 07/2022 - 05/2015
9	Adenocarcinoma 07/2022 - 02/2015
6	Inflammation (Inflammations) 12/2020 - 12/2014
6	Neuroblastoma 02/2017 - 10/2015
6	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2017 - 05/2010
6	Leukemia 01/2017 - 05/2010
4	Neoplasm Metastasis (Metastasis) 07/2022 - 05/2017
4	Alzheimer Disease (Alzheimer's Disease) 02/2022 - 01/2015
4	Poisoning 01/2017 - 10/2012
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2021 - 07/2015
3	Necrosis 01/2021 - 11/2014
3	Atherosclerosis 04/2020 - 07/2016
3	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2020 - 10/2013
3	Carbon Monoxide Poisoning (Poisoning, Carbon Monoxide) 01/2017 - 10/2012
2	Prostatic Neoplasms (Prostate Cancer) 08/2022 - 01/2020
2	Nervous System Diseases (Neurological Disorders) 02/2022 - 10/2013
2	Inborn Genetic Diseases (Disease, Hereditary) 02/2021 - 03/2016
2	Toxocariasis 01/2021 - 12/2020
2	Hyperglycemia 10/2019 - 09/2016
2	Metabolic Diseases (Metabolic Disease) 10/2019 - 09/2016
2	Diabetes Mellitus 10/2019 - 09/2016

Drug/Important Bio-Agent (IBA)

35	Pharmaceutical PreparationsIBA 07/2022 - 05/2010
27	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2022 - 02/2015
24	AGRO 100IBA 12/2022 - 09/2014
18	Proteins (Proteins, Gene)FDA Link 02/2022 - 10/2013
17	APTIBA 09/2022 - 10/2013
17	NucleolinIBA 07/2022 - 09/2014
14	DNA (Deoxyribonucleic Acid)IBA 12/2022 - 06/2013
13	Biomarkers (Surrogate Marker)IBA 08/2022 - 02/2011
11	Peptides (Polypeptides)IBA 02/2022 - 10/2015
10	Epirubicin (Ellence)FDA LinkGeneric 01/2022 - 09/2013
10	LigandsIBA 09/2020 - 06/2015
9	Small Interfering RNA (siRNA)IBA 01/2022 - 04/2015
8	CamptothecinIBA 01/2022 - 03/2017
8	Nucleotide AptamersIBA 10/2021 - 06/2015
7	PolyethyleneimineIBA 09/2018 - 05/2015
6	PolymersIBA 07/2022 - 03/2016
6	Epithelial Cell Adhesion MoleculeIBA 12/2021 - 02/2015
6	Adenosine Triphosphate (ATP)IBA 02/2021 - 05/2016
6	crocinIBA 01/2021 - 05/2013
6	Silicon Dioxide (Silica)FDA LinkGeneric 01/2021 - 06/2017
6	Dendrimers (Dendrons)IBA 10/2018 - 04/2016
5	MicellesIBA 01/2022 - 01/2018
5	AntioxidantsIBA 01/2021 - 01/2012
5	GoldIBA 11/2020 - 07/2015
5	ChitosanIBA 11/2020 - 11/2014
5	5TR1 aptamerIBA 09/2020 - 04/2016
5	Polylactic Acid-Polyglycolic Acid CopolymerIBA 03/2019 - 01/2016
4	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 01/2022 - 11/2020
4	EnzymesIBA 09/2020 - 01/2012
4	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 09/2020 - 11/2015
4	VaccinesIBA 04/2020 - 12/2015
4	Carbon Nanotubes (Carbon Nanotube)IBA 01/2017 - 02/2011
4	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2017 - 10/2012
4	Daunorubicin (Cerubidine)FDA LinkGeneric 04/2016 - 05/2010
3	Antineoplastic Agents (Antineoplastics)IBA 01/2022 - 10/2017
3	Dextrans (Dextran)FDA Link 01/2022 - 10/2017
3	monomethoxypolyethyleneglycol- polylactide block copolymerIBA 12/2020 - 10/2017
3	Eosine Yellowish-(YS) (Eosin)IBA 12/2020 - 01/2013
3	Hematoxylin (Haematoxylon)IBA 12/2020 - 01/2013
3	Folic Acid (Vitamin M)FDA LinkGeneric 12/2020 - 03/2016
3	Biological ProductsIBA 10/2019 - 01/2018
3	Insulin (Novolin)FDA Link 10/2019 - 04/2016
3	Nucleic AcidsIBA 01/2019 - 06/2013
3	liposomal doxorubicin (Doxil)FDA Link 12/2018 - 03/2016
3	polyethylene glycol-poly(lactide-co-glycolide)IBA 10/2017 - 02/2015
3	Acrolein (Aqualin)IBA 01/2015 - 01/2012
2	PicoGreenIBA 08/2022 - 09/2019
2	Cruciform DNA (Holliday Junctions)IBA 08/2022 - 11/2018
2	Fluorescent Dyes (Fluorescent Probes)IBA 08/2022 - 09/2019
2	SurvivinIBA 01/2022 - 11/2020
2	Mucin-1 (CA 15-3 Antigen)IBA 01/2022 - 04/2019
2	SMAC peptideIBA 01/2022 - 09/2020
2	SolventsIBA 12/2021 - 04/2017
2	Malathion (Karbofos)FDA LinkGeneric 01/2021 - 03/2020
2	Subunit VaccinesIBA 01/2021 - 12/2020
2	poly(lactide) (polylactic acid)IBA 09/2020 - 01/2019
2	A-Form DNA (A-DNA)IBA 08/2020 - 09/2014
2	Mitoxantrone (Novantrone)FDA LinkGeneric 05/2020 - 01/2015
2	Cholesterol Ester Transfer ProteinsIBA 04/2020 - 07/2016
2	BuffersIBA 04/2020 - 12/2016
2	PesticidesIBA 03/2020 - 02/2018
2	AcidsIBA 01/2020 - 11/2017
2	Docetaxel (Taxotere)FDA Link 01/2020 - 11/2016
2	galbanic acidIBA 01/2020 - 01/2019
2	AntigensIBA 01/2020 - 11/2017
2	MicroRNAs (MicroRNA)IBA 09/2019 - 09/2017
2	Melitten (Melittin)IBA 04/2019 - 06/2018
2	Glycoproteins (Glycoprotein)IBA 04/2019 - 12/2018

Therapy/Procedure

48	Therapeutics 07/2022 - 01/2013
14	Drug Therapy (Chemotherapy) 01/2022 - 10/2013
12	Precision Medicine 07/2022 - 03/2016
4	Intravenous Injections 01/2022 - 07/2015
3	Quantum Dots (Quantum Dot) 03/2020 - 09/2014
3	Injections 10/2019 - 04/2016